Insider Transactions in Q1 2022 at Relmada Therapeutics, Inc. (RLMD)
Insider Transaction List (Q1 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jan 03
2022
|
Paul Edward Kelly Director |
SELL
Exercise of conversion of derivative security
|
Direct |
20,000
-9.65%
|
$60,000
$3.24 P/Share
|